Form 4: Vivani Medical Director Acquires $5 Million in Shares Through Private Sale

Gregg Williams, a director at Vivani Medical, purchased 3,968,253 shares of common stock in a private sale for $5 million, increasing his total holdings to over 18 million shares.

Summary

• Gregg Williams, a director and 10% owner of Vivani Medical, acquired 3,968,253 shares of common stock through a private sale.
• The purchase price was $1.26 per share, totaling $5,000,000.00 in gross proceeds.
• The price was determined as the lower of the closing price or the 5-day average closing price of Vivani's stock on Nasdaq prior to the closing date.
• Following the transaction, Williams directly owns 4,695,861 shares and indirectly owns 13,677,308 shares, bringing his total ownership to over 18 million shares.
• The indirect ownership is held through various trusts and LLCs, over which Williams has voting and dispositive power.

Sentiment

Score: 7

Explanation: The sentiment is positive due to the director's significant investment, indicating confidence in the company. However, it's a routine transaction and doesn't necessarily signal a major shift in the company's outlook.

Positives

• A director's significant investment demonstrates confidence in the company's future.
• The private sale provides Vivani Medical with $5 million in capital.

Risks

• The private sale could potentially dilute existing shareholders if not managed carefully.
• The director's large ownership stake could give him significant influence over the company.

Industry Context

Insider transactions are common in the biotech industry, and this purchase by a director is a sign of confidence in the company's prospects. It is not uncommon for directors to increase their holdings in companies they believe in.

Comparison to Industry Standards

• Insider purchases are a common occurrence in publicly traded companies, particularly in the biotech sector where executives and directors often have a strong understanding of the company's potential.
• The size of this transaction, $5 million, is significant and indicates a strong belief in the company's future prospects.
• Compared to other similar transactions, this purchase is relatively large for a single director, suggesting a high level of confidence.
• Other biotech companies often see similar insider transactions, but the specific details such as the price and volume are unique to each situation.

Stakeholder Impact

• The purchase could positively impact shareholder confidence.
• The capital injection could benefit the company's operations and development.

Key Dates

Keywords

Vivani Medical, Gregg Williams, insider trading, private sale, share purchase, beneficial ownership, director, common stock